EPHEDRINE MARKET ANALYSIS

Ephedrine Market, By Dosage Form (Tablets, Capsules, and Injections), By Disease Indication (Bronchial Asthma, Spinal Anesthesia induced Hypotension, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI3320
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

However, restrictions on ephedrine usage through regulatory authorities is expected to restrain the market over the forecast period. For instance, since 2001, the Government of Canada has authorized ephedrine only as a nasal decongestant with a maximum dosage of 8mg along with 32mg in a 24 hour period.